CoChat

Long-Term Mortality with Cardiac Resynchronization Therapy in the Cardiac Resynchronization-Heart Failure (CARE-HF) Trial

Open access
Cleland, John G.F., Freemantle, Nick, Erdmann, Erland, Gras, Daniel, Kappenberger, Lukas, Tavazzi, Luigi, Daubert, Jean-Claude · 2012 · European Journal of Heart Failure
Cited by 152

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Aims: The Cardiac Resynchronization-Heart Failure (CARE-HF) study helped establish an important role for cardiac resynchronization therapy (CRT) in the management of selected patients with heart failure. We now report the long-term outcome during and subsequent to the randomized trial. Methods and results: Enrolment was completed in March 2003. After reporting the main study results in 2005, investigators were asked to inform patients of the results and implant a CRT device if still appropriate. Subsequently, investigators were asked to consent patients for long-term follow-up until 30 September 2009. Of 813 patients originally enrolled, 343 (42%) died prior to re-consent, 111 patients (14%) were not or could not be contacted, 50 (6%) were alive but declined to participate, and 309 (38%) consented to long-term follow-up. Of patients originally assigned to the control group, > 95% of survivors had received CRT by the time of re-consent. From the time of randomization, 222 patients originally assigned to pharmacological therapy and 192 originally assigned to CRT were known to have died. The hazard ratio for mortality in patients originally assigned to CRT compared with those originally assigned to the control group was 0.77 (95% confidence interval 0.63–0.93; P = 0.007). No subgroup interactions were observed. Conclusion: The effect of CRT on mortality observed during the randomized CARE-HF trial persisted during long-term follow-up. A high rate of CRT device implantation in the control group after completion of the randomized phase of the study may have prevented further divergence of the survival curves.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurjhf/hfs055

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 152

Metadata

Authors
Cleland, J. G. F., Freemantle, N., Erdmann, E., Gras, D., Kappenberger, L., Tavazzi, L., & Daubert, J.-C.
Venue
European Journal of Heart Failure
Published
2012-06-01
Volume
14
Issue
6
Pages
628-634
ISSN
  • 1388-9842 (ISSN-L)
  • 1879-0844
OpenAlex
W2058544125
Cited by
152
References
6
FWCI
8.06
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Long-Term Mortality with Cardiac Resynchronization Therapy in the Cardiac Resynchronization-Heart Failure (CARE-HF) Trial. https://app.cochat.ai/papers/10.1093/eurjhf/hfs055
The paper
Cleland, J. G. F., Freemantle, N., Erdmann, E., Gras, D., Kappenberger, L., Tavazzi, L., & Daubert, J.-C. (2012). Long-Term Mortality with Cardiac Resynchronization Therapy in the Cardiac Resynchronization-Heart Failure (CARE-HF) Trial. European Journal of Heart Failure. https://doi.org/10.1093/eurjhf/hfs055

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.